DGAP-News

Avagenesis Corp. Receives ISO 13485 and 9001 for Bioprocessing and Cell Isolation System - Seite 2

future performance. The use of any of the words 'could', 'intend',
'expect', 'believe', 'will', 'projected', 'estimated' and similar
expressions and statements relating to matters that are not historical
facts are intended to identify forward-looking information and are based on
Avagenesis' current belief or assumptions as to the outcome and timing of
such future events. Actual future results and developments may differ
materially from those contemplated by these statements depending on, among
other things, the risk that Avagenesis may not successfully transition to a
clinical stage company and the risk that Avagenesis may not successfully
execute its development and commercialization activities. Various
assumptions or factors are typically applied in drawing conclusions or
making the forecasts or projections set out in forward-looking information.
Those assumptions and factors are based on information currently available
to Avagenesis. Avagenesis cautions the reader that the above list of risk
factors is not exhaustive. The forward-looking information contained in
this press release is made as of the date hereof and Avagenesis is not
obligated to update or revise any forward-looking information, whether as a
result of new information, future events or otherwise, except as required
by applicable securities laws. Because of the risks, uncertainties and
assumptions contained herein, investors should not place undue reliance on
forward-looking information. The foregoing statements expressly qualify any
forward-looking information contained herein.

Further Information

For further information, please contact:

Avagenesis Corp.
Alan Tam, PFP, CPA, CA
Chief Financial Officer
Telephone: [phone]


Click on, or paste the following link into your web browser, to view
the associated documents

http://www.newsfilecorp.com/release/17114

News Source: Newsfile



---------------------------------------------------------------------

03.09.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language: English
Company: Avagenesis Corp.


Canada
ISIN: CA05337F1099


End of News DGAP News Service
---------------------------------------------------------------------
392475 03.09.2015